Actelion has announced only 1 M&A deal since 2009, with the deal being the acquisition of Ceptaris Therapeutics.Abstracted from: Partnering Agreements with Actelion 2009-2014
Actelion is involved in M&A activity for growth similar to its peers in the list of top pharmaceutical / biotechnology companies. Actelion has strengthened its position in the oncology market with its acquisition of Ceptaris.
Actelion acquired the company Ceptaris in 2013 for a purchase price of $250 million after the approval of the T-cell lymphoma drug that Ceptaris produced.
Actelion announced the termination of its option to acquire Trophos following the communication of phase III results in patients suffering from amyotrophic lateral sclerosis (ALS).
View the full details of the deals at Current Agreements (subscription required)
Our report provides more detailed insight into the details of each deal. See: Partnering Agreements with Actelion 2009-2014
Full details on each deal can be found at CurrentAgreements (subscription required)
Or purchase report: Partnering Agreements with Actelion 2009-2014
Partnering interests for Actelion
Available reports from Current Partnering
Report: Partnering Agreements with Actelion 2009-2014
Report: Partnering Deals and Alliances with Big Biotech
Available resources for deal coverage for Actelion
Read: more on Actelion company profile, recent partnering, M&A and financing news and articles
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk